CJC 1295 (with DAC)

Description

1. GH‑IGF‑1 axis research: activates pituitary GHRH receptor to investigate growth hormone and IGF‑1 secretion regulation.
2. Body‑composition study: researches lean mass retention and fat mass modulation in pre‑clinical animal models.
3. Aging endocrinology: explores age‑related decline of hypothalamic‑pituitary GH secretion.
4. Long‑acting peptide pharmacology: studies pharmacokinetics and dose‑response of DAC‑lipid modified peptide.